Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure- Hagens Berman
(NasdaqGM:IOVA), SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) — Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025. Mr. Bellemin, who assumed the CFO role in November 2020, is reportedly departing to pursue other endeavors, according to a regulatory […]